Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Sysco Reports Fourth Quarter and Full Year 2024 Results
-
KFC Western Europe selects Trace One PLM to maximize data-driven brand and customer experiences
-
Arbe to Participate at August Investor Conferences
-
Smith+Nephew partners with HOPCo to provide AI-powered analytics and solutions to ASC customers
-
Liquidity Services Relocates and Expands Its Indianapolis Operation
-
Alliance Trust PLC - Net Asset Value
-
Net Asset Value(s)
-
SKYX Announces a Collaboration with Home Depot for its Advanced and Smart Plug & Play Products for both Retail and Professional Segments
-
SKYX Announces a Collaboration with Home Depot for its Advanced and Smart Plug & Play Products for both Retail and Professional Segments
-
TC Energy announces Canada’s largest Indigenous equity ownership agreement
-
Century Fire Protection Acquires Citadel Fire Sprinkler and Sentry Fire Protection
-
Novacium’s Silicon-Based Batteries with GEN3 Anode Material Surpass 4,000 mAh
-
VitalHub Corp. to Acquire MedCurrent Corporation
-
ISO certification reinforces RTOERO’s strong commitment to environmental performance
-
Repligen Reports Second Quarter 2024 Financial Results
-
Cytokinetics Announces Call for Proposals for Corporate Giving Program
-
DT Midstream Reports Strong Second Quarter 2024 Results
-
Watsco Reports Record Sales, Enhanced Operating Efficiency and Strong Cash Flow During Second Quarter
-
Intellia Therapeutics Receives Authorization to Initiate Phase 1/2 Clinical Trial of NTLA-3001 for the Treatment of Alpha-1 Antitrypsin Deficiency
-
Highwire Expands Leadership Team with Chuck Hemann as First Chief Integration Officer
-
Ocular Therapeutix™ Announces First Patients Enrolled in Phase 3 SOL-R Wet AMD Study
-
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
-
SL Green Extends Mortgage on 220 East 42nd Street
-
Day One Reports Second Quarter 2024 Financial Results and Corporate Progress
-
Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease
-
Hubbell Reports Second Quarter 2024 Results
-
InflaRx to Present New Preclinical Data on INF904 at the 19th European Meeting on Complement in Human Diseases
-
Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X
-
Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference
-
Ferrari N.V.: Periodic Report on the Buyback Program
-
ADC Therapeutics to Host Second Quarter 2024 Financial Results Conference Call on August 6, 2024
-
Goliath Intercepts 35.04 g/t AuEq (1.13 oz/t AuEq) Over 6.34 Meters ~True Width, Two Deeper Intercepts Have Assays Pending, Surebet Discovery, Golden Triangle, B.C. – System Remains Wide Open
-
Man Group PLC : Form 8.3 - Darktrace plc
-
Man Group PLC : Form 8.3 - Spirent Communications plc
-
Man Group PLC : Form 8.3 - Bellway plc
-
Uber Freight Drives Significant Growth in Canada with Innovative LTL Solutions
-
Aben Minerals Completes Sale of Mineral Claims
-
Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
-
Colliers Completes Acquisition of Englobe
-
Defiance ETFs Announces Monthly Distributions on $QQQY (71.41%), $JEPY (42.47%), $IWMY (73.90%), $SPYT (20.03%), $USOY (51.14%), and QQQT (20.01%)
-
BioXcel Therapeutics to Report Second Quarter 2024 Financial Results on August 6, 2024
-
BioCardia Submits for FDA Approval of Morph® DNA™ Steerable Introducer Product Family
-
OneWater Marine Inc. Announces Fiscal Third Quarter 2024 Results
-
Angus Gold Continues to Improve Grade of BIF-Hosted Gold System, Intersects 1.1 g/t Au over 47.4 metres including 2.2 g/t Au over 11.7 metres, Golden Sky Project, Wawa
-
Eloro Provides Update on Iska Iska Silver-Tin Polymetallic Project, Potosi Department, Southwestern Bolivia
-
H&E Equipment Services, Inc. Reports Second Quarter 2024 Results
-
Amicus Therapeutics to Announce Second Quarter 2024 Financial Results on August 8, 2024
-
The Devon Group and WorkTech Announce Alliance to Support Burgeoning HR Technology Community
-
Foresight Diagnostics Expands Series B Financing to $73.75 Million to Advance the Foresight CLARITY™ MRD Platform
-
Voyager Therapeutics Announces Second Quarter 2024 Conference Call and Webcast

